According to WHO guidelines, what is the recommended treatment duration for leprosy?
In a community, 30% of the population is below 15 years of age and 10% is over 65 years of age. What is the dependency ratio of this community?
What is 'Epornithic'?
What is the immunization given at the 9th month of age?
Which geographical region in India was identified as being suitable for mass DEC-medicated salt treatment for lymphatic filariasis due to its safety, low cost, and effectiveness?
What is the modified plan of operation for Malaria based on?
What does one DALY signify?
Prevalence of tuberculosis infection is determined by which of the following methods?
The Human Development Index (HDI) includes all of the following components EXCEPT:
Iron and folic acid supplementation primarily serves what purpose in public health?
Explanation: The WHO Multi-Drug Therapy (MDT) regimen is the gold standard for leprosy treatment, designed to prevent drug resistance and ensure complete cure. **Explanation of the Correct Answer:** * **Option C is correct:** According to WHO guidelines, **Paucibacillary (PB) leprosy** (1–5 skin lesions, negative skin smears) is treated for a fixed duration of **6 months** with a two-drug regimen: Rifampicin (once monthly, supervised) and Dapsone (daily, self-administered). The treatment is standardized to ensure high compliance and efficacy. **Analysis of Incorrect Options:** * **Option A:** This reflects outdated practices. Current WHO guidelines use **Fixed Duration Therapy (FDT)**. For Multibacillary (MB) leprosy, the duration is fixed at **12 months**, regardless of smear results. Slit-skin smears are no longer used to determine the end of treatment. * **Option B:** Leprosy is a curable bacterial infection. Lifelong treatment is never indicated; even in relapse, a standard course of MDT is repeated. * **Option D:** WHO provides very specific, evidence-based protocols for both PB and MB leprosy to guide global elimination programs. **High-Yield Clinical Pearls for NEET-PG:** * **MB Leprosy Regimen (12 months):** Rifampicin, Dapsone, and **Clofazimine**. * **PB Leprosy Regimen (6 months):** Rifampicin and Dapsone. * **Accompanied MDT (A-MDT):** Provided to patients who have difficulty accessing clinics, allowing them to take the full course home. * **Single Lesion PB:** Previously treated with ROM (Rifampicin, Ofloxacin, Minocycline), but current WHO guidelines recommend the standard 6-month PB regimen for all PB cases. * **Rifampicin** is the most bactericidal component of the MDT.
Explanation: ### Explanation **1. Understanding the Concept** The **Dependency Ratio** is a demographic indicator that measures the burden on the productive part of the population. It is defined as the ratio of the "dependent" population (those not typically in the labor force) to the "productive" population (the working-age group). * **Dependents:** Children (0–14 years) + Elderly (65 years and above). * **Productive Age Group:** Adults aged 15–64 years. **Calculation for this question:** * **Dependents:** 30% (below 15) + 10% (over 65) = **40%** * **Productive Group:** 100% – 40% = **60%** * **Formula:** $\frac{\text{Population (0-14) + Population (65+)}}{\text{Population (15-64)}} \times 100$ * **Calculation:** $\frac{40}{60} \times 100 = \mathbf{66.66\%}$ **2. Analysis of Incorrect Options** * **Option A (30%):** This represents only the Young Age Dependency Ratio, ignoring the elderly. * **Option B (20%):** This is a distractor with no mathematical basis in the dependency formula. * **Option C (40%):** This is the total percentage of dependents in the *entire* population. However, the ratio must be calculated against the *working-age* population (the denominator), not the total population. **3. High-Yield Clinical Pearls for NEET-PG** * **Young Age Dependency Ratio:** $\frac{0-14 \text{ years}}{15-64 \text{ years}} \times 100$. * **Old Age Dependency Ratio:** $\frac{65+ \text{ years}}{15-64 \text{ years}} \times 100$. * **Total Dependency Ratio:** Sum of the above two. * **Demographic Dividend:** Occurs when the dependency ratio declines due to a bulge in the working-age population, potentially leading to economic growth. * **India’s Context:** In many Indian textbooks, the working age is sometimes cited as 15–59 years. However, for international comparisons and standard MCQ patterns, **15–64 years** is the global benchmark. Always check the denominator based on the age groups provided in the stem.
Explanation: ### Explanation **1. Why Option A is Correct:** The term **Epornithic** is derived from the Greek words *'epi'* (upon) and *'ornis'* (bird). In veterinary epidemiology, it refers to an outbreak of an infectious disease in a bird population that rises to levels significantly higher than what is normally expected in a specific geographic area. It is the avian equivalent of an "epidemic" in humans. A classic example is the outbreak of Highly Pathogenic Avian Influenza (H5N1). **2. Why Other Options are Incorrect:** * **Option B (Fishes):** An epidemic outbreak among fish populations is termed **Epichthonic** (though this is less commonly tested). * **Option C (Imported Disease):** A disease introduced into a country where it does not normally occur is called an **Exotic disease** (e.g., Lassa fever in India). * **Option D (Animals):** An epidemic outbreak among non-human animals (mammals) is termed **Epizootic**. If the disease is constantly present in an animal population at a baseline level, it is called **Enzootic**. **3. High-Yield Clinical Pearls for NEET-PG:** * **Epornitic vs. Epizootic:** Remember 'Ornithology' is the study of birds; hence, **Epornithic** is for birds. * **Zoonosis:** A disease naturally transmissible from vertebrate animals to humans (e.g., Rabies, Brucellosis). * **Epizootic Cycle:** Often precedes a human epidemic in zoonotic diseases (e.g., West Nile Virus or Plague). * **Enzootic:** The animal equivalent of "Endemic." * **Preadaptation:** The process where a virus circulating in an epornithic or epizootic state gains mutations to infect humans.
Explanation: **Explanation:** In the National Immunization Schedule (NIS) of India, the **9th month** marks a critical transition in a child’s immunity. The correct answer is **Measles** (now commonly administered as the **MR vaccine**—Measles and Rubella). **Why Measles?** Before 9 months, infants are generally protected by maternal antibodies (IgG) transferred across the placenta. By 9 months, these maternal antibodies wane, making the infant susceptible to infection. Administering the vaccine earlier may lead to neutralization by maternal antibodies, while delaying it increases the risk of severe complications like pneumonia or encephalitis. Along with the MR vaccine, the **1st dose of Vitamin A (1 lakh IU)** and the **PCV Booster** are also administered at this time. **Analysis of Incorrect Options:** * **BCG (Bacillus Calmette–Guérin):** Given **at birth** (or as soon as possible up to 1 year) to protect against severe forms of childhood tuberculosis. * **DPT (Diphtheria, Pertussis, Tetanus):** The primary series is given at **6, 10, and 14 weeks** (as part of the Pentavalent vaccine). DPT boosters are given later at 16–24 months and 5–6 years. **High-Yield Clinical Pearls for NEET-PG:** * **Route & Site:** MR vaccine is given **Subcutaneously (SC)** in the right upper arm. * **JE Vaccine:** In endemic districts, the 1st dose of Japanese Encephalitis vaccine is also given at 9 months. * **Zero Dose:** "Zero dose" refers to OPV given at birth; it is not counted in the primary 3-dose schedule. * **Vitamin A:** Total 9 doses are given until 5 years of age (Total dose: 17 lakh IU).
Explanation: **Explanation:** The correct answer is **Lakshadweep islands**. **Why Lakshadweep is correct:** Mass administration of **Diethylcarbamazine (DEC)-medicated salt** is a specialized strategy for the elimination of lymphatic filariasis. This method involves replacing common salt with salt fortified with 0.1% to 0.4% DEC. The **Lakshadweep islands** were identified as the ideal geographical region for this intervention because the islands are geographically isolated, have a closed market for salt supply (making it easier to monitor and control the distribution), and have a high endemicity of filariasis. Studies conducted here demonstrated that medicated salt is safe, inexpensive, and highly effective in reducing microfilaria rates compared to annual mass drug administration (MDA) alone. **Why other options are incorrect:** * **Goa, Daman and Diu:** While these are coastal areas where filariasis may be endemic, they are not geographically isolated "closed systems." The open trade routes and multiple sources of salt supply make the logistics of ensuring 100% coverage with medicated salt nearly impossible. * **Andaman and Nicobar islands:** Although isolated, the landmark pilot studies and successful large-scale implementation specifically cited in Indian public health literature and the National Health Programs focus on the Lakshadweep experience as the primary model for DEC-salt efficacy. **High-Yield Clinical Pearls for NEET-PG:** * **DEC-Salt Concentration:** Usually **0.1% to 0.2% w/w** is used for 6–12 months. * **Advantages:** No "side effects" typically seen with bolus doses (like the Mazzotti reaction) because the drug dose is low and continuous. * **Drug of Choice:** DEC is the drug of choice for Lymphatic Filariasis (except in cases of co-infection with Onchocerciasis). * **National Target:** India aims for the elimination of Lymphatic Filariasis by **2027** (three years ahead of the global target).
Explanation: ### Explanation The **Modified Plan of Operation (MPO)** was launched in **1977** under the National Malaria Eradication Programme (NMEP) after a massive resurgence of malaria in India. Its primary objective was to prevent deaths and reduce morbidity through a decentralized approach. **Why API is the correct answer:** The MPO shifted the strategy from "eradication" to "control." The intensity of anti-malarial activities (specifically Indoor Residual Spraying or IRS) was determined by the **Annual Parasite Incidence (API)**. * Areas with an **API of 2 or above** were classified as high-risk and received regular insecticidal spraying. * Areas with an **API below 2** received focal spraying only. API is calculated as: *(Total number of positive slides in a year / Total population)* × 1000. **Analysis of Incorrect Options:** * **B. ABER (Annual Blood Examination Rate):** This measures the efficiency of the surveillance system (operational efficiency). While crucial for monitoring, it is not the criteria used to categorize areas for the MPO strategy. * **C. Spleen Rate:** This is a measure of **endemicity** (prevalence) in a community, traditionally used in children aged 2–9 years. It does not guide the current operational planning of the national program. * **D. Infant Parasite Rate:** This is the most sensitive index to measure the **recent transmission** of malaria in a locality. If the IPR is zero for three consecutive years, it indicates the absence of malaria transmission. **High-Yield NEET-PG Pearls:** * **API ≥ 2:** Threshold for regular IRS under MPO. * **ABER:** Should ideally be **10% or more** to ensure adequate surveillance. * **SPR (Slide Positivity Rate):** Used to monitor the trend of the disease in a specific area. * **Pf% (P. falciparum percentage):** Vital for monitoring the shift toward the more dangerous species of malaria.
Explanation: **Explanation:** The **Disability-Adjusted Life Year (DALY)** is a summary measure of population health used to quantify the "burden of disease." It was developed by the World Bank and the WHO to compare the impact of different diseases across populations. **Why Option B is correct:** One DALY represents the loss of the equivalent of **one year of full health**. It is a composite indicator calculated by summing two components: 1. **YLL (Years of Life Lost):** Due to premature mortality (dying before the expected age). 2. **YLD (Years Lived with Disability):** Due to living with a health condition or its consequences. *Formula: DALY = YLL + YLD* **Why other options are incorrect:** * **Option A:** A "disease-free year" is more closely related to **Quality-Adjusted Life Years (QALY)**, which measures the *gain* or quality of life rather than the *burden* or loss. * **Option C:** DALYs are measured in **years**, not months. Furthermore, "bedridden life" is too narrow; disability in DALYs covers any deviation from perfect health, ranging from mild impairment to severe disability. **High-Yield Clinical Pearls for NEET-PG:** * **QALY vs. DALY:** QALY measures "utility" (benefit of intervention), while DALY measures "burden" (impact of disease). * **Global Burden of Disease (GBD):** The DALY is the primary metric used in GBD studies. * **Weighting:** In DALY calculations, different disabilities are assigned a "disability weight" ranging from 0 (perfect health) to 1 (death). * **Mental Health:** DALYs are particularly useful for highlighting the burden of non-fatal conditions like depression, which have high YLD but low YLL.
Explanation: ### Explanation The key to answering this question lies in distinguishing between **Tuberculosis Infection** (latent) and **Tuberculosis Disease** (active). **Why Option B is Correct:** The **Mantoux test (Tuberculin Skin Test)** is the standard epidemiological tool used to estimate the **prevalence of infection** in a community. It measures delayed-type hypersensitivity to Purified Protein Derivative (PPD). A positive result indicates that the individual’s immune system has encountered *M. tuberculosis* antigens before, regardless of whether they have active clinical symptoms. In India, the **Annual Risk of Tuberculous Infection (ARTI)** is calculated based on Mantoux surveys among children. **Why Other Options are Incorrect:** * **A. Sputum Examination:** This is the gold standard for diagnosing **active pulmonary TB disease** and determining the **prevalence of infectious cases** (bacillary prevalence). It does not detect latent infection. * **C. Clinical Examination:** This identifies symptomatic patients (cough, fever, weight loss). It is unreliable for prevalence surveys as it misses asymptomatic infections and lacks specificity. * **D. MMR Vaccine Status:** This is irrelevant to tuberculosis. BCG is the vaccine associated with TB, though it can cause a false-positive Mantoux result. **High-Yield Clinical Pearls for NEET-PG:** * **Prevalence of Infection:** Measured by Mantoux Test. * **Prevalence of Disease:** Measured by Sputum culture/smear and Chest X-ray. * **Incidence of TB:** Best measured by the number of new cases (Notification rates). * **Mantoux Reading:** Read after **48–72 hours**. In India, an induration of **≥10 mm** is generally considered positive. * **ARTI:** A 1% ARTI corresponds to approximately 50 new smear-positive cases per 100,000 population.
Explanation: The **Human Development Index (HDI)** is a composite statistical tool used by the UNDP to measure a country's social and economic development. It focuses on three basic dimensions of human development, each measured by specific indicators. ### Why "Infant Mortality Rate" is the Correct Answer: **Infant Mortality Rate (IMR)** is not a component of the HDI. Instead, IMR is a key indicator used in the **Physical Quality of Life Index (PQLI)**. While IMR reflects the health status of a population, the HDI uses **Life Expectancy at Birth** to represent the health dimension. ### Explanation of Incorrect Options: * **Life Expectancy at Birth (Option D):** This is the indicator for the **"Long and Healthy Life"** dimension. It represents the health component of the HDI. * **Adult Literacy Rate (Option A):** This is a component of the **"Knowledge"** dimension. Education is measured by a combination of Mean Years of Schooling (for adults) and Expected Years of Schooling (for children). * **Per Capita Income (Option C):** This represents the **"Standard of Living"** dimension. It is specifically measured as Gross National Income (GNI) per capita at Purchasing Power Parity (PPP) in USD. ### High-Yield NEET-PG Pearls: * **HDI Components (3 Dimensions, 4 Indicators):** 1. **Health:** Life expectancy at birth. 2. **Education:** Mean years of schooling & Expected years of schooling. 3. **Standard of Living:** GNI per capita (PPP $). * **PQLI vs. HDI:** PQLI includes IMR, Life Expectancy at Age 1, and Literacy Rate. It does **not** include income. * **HDI Range:** Values range from 0 to 1. A score of >0.800 is considered "Very High Human Development." * **Goalpost for HDI:** The maximum value for life expectancy used in calculations is 85 years, and the minimum is 20 years.
Explanation: ### Explanation The correct answer is **Specific Protection** because iron and folic acid (IFA) supplementation is a targeted intervention aimed at preventing a specific disease—nutritional anemia—in vulnerable populations. **1. Why Specific Protection is Correct:** Specific protection is a component of **Primary Prevention**. It involves measures applicable to a particular disease or group of diseases to intercept the causes before they involve the biological system. Since IFA tablets are administered to provide the body with the exact nutrients needed to prevent iron-deficiency anemia and neural tube defects, it falls squarely under this category. Other examples include immunizations and the use of helmets. **2. Why Other Options are Incorrect:** * **Health Promotion (Option A):** This is the other component of primary prevention but is non-specific. it aims at strengthening the host through lifestyle changes, health education, and environmental modifications (e.g., a balanced diet) rather than a specific nutrient supplement. * **Primordial Prevention (Option B):** This focuses on preventing the *emergence* of risk factors in a population where they have not yet appeared (e.g., discouraging children from starting smoking). Since the risk factor (nutritional deficiency) already exists in the population, IFA is primary, not primordial. * **Secondary Prevention (Option C):** This involves "early diagnosis and treatment" (e.g., screening programs). IFA supplementation is given to prevent the onset of anemia, not to detect it after it has developed. **High-Yield Clinical Pearls for NEET-PG:** * **Anemia Mukt Bharat (AMB) Strategy:** Uses a **6x6x6 strategy** (6 age groups, 6 interventions, 6 institutional mechanisms). * **Prophylactic Dose (AMB):** For pregnant women, the regimen is **100 mg elemental iron and 500 mcg folic acid** daily for 180 days, starting from the second trimester. * **Levels of Prevention:** Remember the sequence: Primordial (Risk factor absent) → Primary (Risk factor present, disease absent) → Secondary (Early disease) → Tertiary (Late disease/disability).
Principles of Epidemiology
Practice Questions
Measures of Disease Frequency
Practice Questions
Epidemiological Study Designs
Practice Questions
Descriptive Epidemiology
Practice Questions
Analytical Epidemiology
Practice Questions
Experimental Epidemiology
Practice Questions
Screening for Disease
Practice Questions
Surveillance Systems
Practice Questions
Investigation of an Epidemic
Practice Questions
Association and Causation
Practice Questions
Modern Epidemiological Methods
Practice Questions
Critical Appraisal of Epidemiological Studies
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free